Time-invariant system

Genius Litter Partners with Animal Shelters to Give Back Proceeds from Retail Purchases

Retrieved on: 
Wednesday, February 8, 2023

This litter brand is excited to be featuring their products in popular retail chains in the United States and Canada in January 2023.

Key Points: 
  • This litter brand is excited to be featuring their products in popular retail chains in the United States and Canada in January 2023.
  • Additionally, as this company continues to bring about growth within the pet ownership communities, Genius Litter is taking steps toward new ways to partner with animal shelters.
  • As the company grows, Genius Litter is looking for new ways to get involved in local animal outreach programs.
  • Genius Litter is an odor-fighting, environmentally friendly litter alternative that utilizes a color changing formula to monitor a cat's health.

Iconic Smurfs™ Brand Launches Unique Kids Nutritional Gummies Made With Real Fruit

Retrieved on: 
Tuesday, February 7, 2023

ST. PETERSBURG, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Nutritional supplements just got more fun for kids, and smarter for parents, with new Smurfs Kids Gummies .

Key Points: 
  • ST. PETERSBURG, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Nutritional supplements just got more fun for kids, and smarter for parents, with new Smurfs Kids Gummies .
  • "The Smurfs brand, with its iconic blue characters, brings instant interest to our nutritional gummies," says Dave Bunch, CEO of Growve.
  • We wanted to tap into this rich nostalgia and provide parents a healthier choice to give their kids."
  • "We are so happy with this new collaboration with Growve, launching the Smurfs kids vitamin gummies in North America.

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

Retrieved on: 
Tuesday, January 31, 2023

HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful “Access-Ability Live by MBOT” webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at 1:00pm ET. It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.

Key Points: 
  • It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.
  • He is also a faculty member at the Cardiovascular Research Foundation in New York.
  • Dr. Weisz, who has a particular interest in current and innovative technologies in cardiovascular medicine, is an early adopter of robotic-enhanced coronary interventions, as well as navigation and positioning technologies.
  • The “Access-Ability Live by MBOT” webinar series focuses on key topics in the healthcare and endovascular space.

Global Cardiac Safety Services Market Report 2022 to 2028: Increase in Research for Biosimilars and Biologics Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 18, 2023

The "Global Cardiac Safety Services Market Size, Share & Industry Trends Analysis Report by Type, End-user, Type of Service, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Cardiac Safety Services Market Size, Share & Industry Trends Analysis Report by Type, End-user, Type of Service, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Cardiac Safety Services Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 11.1% CAGR during the forecast period.
  • Due to the grouping of services with an emphasis on end-to-end development, integrated services that provide cardiac safety services are generally favored over standalone services because of the peculiarity of standalone services.
  • As a result of COVID-19's vigorous promotion of its development, the market for cardiac safety services was positively affected overall.

NTT Research to Host Upgrade 2023 Global Innovation Summit

Retrieved on: 
Wednesday, January 18, 2023

NTT Research, Inc. , a division of NTT (TYO:9432), today announced plans to hold Upgrade 2023 , the NTT Research Summit, as an in-person event on March 15-16, 2023.

Key Points: 
  • NTT Research, Inc. , a division of NTT (TYO:9432), today announced plans to hold Upgrade 2023 , the NTT Research Summit, as an in-person event on March 15-16, 2023.
  • The exhibition showcases the most up-to-date innovations occurring at NTT Research in the U.S. and NTT R&D in Japan, and it will take place at the NTT XC, 690 Folsom St., San Francisco.
  • Day 1 events extend from 9 a.m. to 2 p.m.
    Day 2 (March 16) of Upgrade 2023 will include keynote presentations by Kazuhiro Gomi, President & CEO of NTT Research, and Atsuko Oka, EVP and Head of NTT Research and Development (R&D) Planning and member of the NTT Research Board of Directors.
  • For more details on Upgrade 2023, including updates and information on (free) registration, please visit the event’s website and agenda .

MetAlert and TrakTec Agree to Heads of Terms for Acquisition of TrakTec by MetAlert

Retrieved on: 
Wednesday, January 11, 2023

TrakTec makes and sells affordable, scalable location awareness technology solutions for consumer, enterprise, and government applications.

Key Points: 
  • TrakTec makes and sells affordable, scalable location awareness technology solutions for consumer, enterprise, and government applications.
  • TrakTec operates iGPS Watches and SafetyNet® Tracking Systems that offer a range of enhanced monitoring services.
  • The iGPS products include the Wizard GPS Tracking Watch Phone, designed for children, and the Phoenix watch, a GPS-based smart wearable for seniors.
  • “We are extremely excited about the opportunity to acquire TrakTec,” stated MetAlert CEO Patrick Bertagna.

Selectis Health Reports Third Quarter 2022 Results

Retrieved on: 
Monday, January 9, 2023

Greenwood Village, Colorado, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") is reporting financial and operating results for the third quarter ended September 30, 2022.

Key Points: 
  • Greenwood Village, Colorado, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") is reporting financial and operating results for the third quarter ended September 30, 2022.
  • Third Quarter 2022 Summary (vs. Year-Ago Quarter) 1
    Revenue increased 31% to $9.6 million compared to $7.3 million.
  • “During the third quarter, we continued to advance our strategic initiatives and meaningfully increase our portfolio-wide patient census,” said Lance Baller, Chairman and CEO of Selectis.
  • Net loss in the third quarter of 2022 was $1.0 million or $(0.33) per share compared to a net loss of $0.06 million or $(0.02) per share in the year-ago quarter.

Global Defense Logistics Market Report 2023-2027: Sector to Grow by $3.99 Billion - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023

This study identifies the collaborative logistics approach as one of the prime reasons driving the defense logistics market growth during the next few years.

Key Points: 
  • This study identifies the collaborative logistics approach as one of the prime reasons driving the defense logistics market growth during the next few years.
  • Also, the adoption of network-centric warfare communication infrastructure and vehicle management systems for defense logistics players will lead to sizable demand in the market.
  • The report on the defense logistics market covers the following areas:
    The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading defense logistics market vendors that include AECOM, Amentum Services Inc., Anham FZCO LLC, ASELSAN AS, BAE Systems Plc, Colak Group, Crane Worldwide Logistics, Crowley Maritime Corp., Defence Logistics Ltd., Fluor Corp., General Dynamics Corp., Honeywell International Inc., KBR Inc., Leonardo SpA, Northrop Grumman Corp., SEKO Logistics, Thales Group, Wincanton Plc, CEVA Logistics AG, and Lockheed Martin Corp.. Also, the defense logistics market analysis report includes information on upcoming trends and challenges that will influence market growth.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

FIU receives $3 million NIH grant to research how electric stimulation can solve bladder issues

Retrieved on: 
Tuesday, January 10, 2023

The nervous system controls many functions in the body, including the urinary tract.

Key Points: 
  • The nervous system controls many functions in the body, including the urinary tract.
  • Controlling those nerves with electrical pulses could theoretically restore proper bladder function.
  • There are not many therapies available on the market for urinary tract issues today, said Danziger, an expert in this area of biomedical engineering.
  • This completely computerized model of the bladder and its surrounding parts will help scientists focus costly experimental efforts.

Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma

Retrieved on: 
Sunday, January 22, 2023

London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, today announces the agreement to acquire core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.

Key Points: 
  • London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in breakthrough biotechnology companies, today announces the agreement to acquire core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.
  • Arix co-led the Ensoma financing as a new investor, investing $9 million.
  • Twelve Bio is a gene editing company pioneering the therapeutic application of next-generation CRISPR-Cas medicines.
  • Ensoma is a Boston-based genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system.